TGFB1 and neoplasm: Increasing evidence suggests that these immunosuppressive factors, particularly TGF-β derived from the GBM cells themselves, support transition of brain resident/infiltrating immune cells such as microglia and tumor infiltrating myeloid cells to an immunosuppressive phenotype that allows aggressive tumor growth and progression while blocking anti-tumor immune responses (47, 48).